Levels of y-Aminobutyric Acid in Cerebrospinal Fluid in Various Neurologic Disorders
Arch Neurol 37:352-355, Manyam,N.V.B.,et al, 1980
Huntington's Disease, CSF GABA Level in at-risk Individuals
Arch Neurol 35:728-730, Manyam,N.V.B.,et al, 1978
Identification of GABA in Human CSF by Gas Liquid Chromatography & Mass Spectrometry
NEJM 296:692, Huizinga,J.D.,et al, 1977
Treatment of Huntington's Chorea with Isoniazid
NEJM 297:840, 1977. (Letter), Perry,T.L.,et al, 1977
Isoniazid Therapy of Huntington Disease
Neurol 29:370-375, Perry,T.L.,et al, 1979
Huntington's Disease:Treatment with Muscimol, a GABA-Mimetic Drug
Ann Neurol 4:279-284, Shoulson,I.,et al, 1978
Huntington's Chorea, Changes in Neurotransmitter Receptors in the Brain
NEJM 294:1305, Enna,S.J.,et al, 1976
Huntington's Chorea-Deficiency of Y-Aminobutynic Acid in Brain
NEJM 288:337, 1973, 289:104, 1973, 292:10295., Perry,T.,et al, 1975
Cortical Myoclonus in Huntington's Disease
Movement Disorders 9:633-641, Thompson,P.D.,et al, 1994
Myoclonus in Adult Huntington's Disease
Ann Neurol 29:213-215, Vogel,C.M.,et al, 1991
The Role of Glutamate in Neurotransmission & in Neurologic Disease
Arch Neurol 43:1058-1063, Greenamyre,J.T., 1986
Neuropeptides in Neurological Disease
Ann Neurol 20:547-565, Beal,M.F.&Martin,J.B., 1986